tiprankstipranks
Stoke Therapeutics Inc (STOK)
NASDAQ:STOK
US Market
STOK
Stoke Therapeutics
RESEARCH TOOLSreports

Stoke Therapeutics (STOK) Financial Statements

Compare
467 Followers

Stoke Therapeutics Financial Overview

Stoke Therapeutics's market cap is currently $1.99B. The company's EPS TTM is $-0.992; its P/E ratio is -273.00; Stoke Therapeutics is scheduled to report earnings on March 11, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 184.42M$ 36.55M$ 8.78M$ 12.40M$ 0.00
Gross Profit$ 184.42M$ 36.55M$ 8.78M$ 12.40M$ 0.00
Operating Income$ -20.59M$ -101.37M$ -114.77M$ -104.36M$ -86.06M
EBITDA$ -18.82M$ -99.19M$ -112.30M$ -102.81M$ -85.09M
Net Income$ -6.88M$ -88.98M$ -104.70M$ -101.07M$ -85.81M
Balance Sheet
Cash & Short-Term Investments$ 284.67M$ 216.90M$ 201.39M$ 229.59M$ 219.81M
Total Assets$ 418.43M$ 271.56M$ 228.34M$ 256.07M$ 238.87M
Total Debt$ 0.00$ 2.32M$ 2.06M$ 2.36M$ 1.51M
Net Debt$ -84.22M$ -125.66M$ -189.38M$ -111.20M$ -143.39M
Total Liabilities$ 65.98M$ 42.53M$ 68.78M$ 71.22M$ 21.09M
Stockholders' Equity$ 352.46M$ 229.02M$ 159.56M$ 184.85M$ 217.78M
Cash Flow
Free Cash Flow$ 44.91M$ -87.05M$ -82.68M$ -35.83M$ -68.11M
Operating Cash Flow$ 45.59M$ -86.85M$ -81.07M$ -31.87M$ -66.91M
Investing Cash Flow$ -186.81M$ -107.47M$ 105.95M$ -45.88M$ -76.43M
Financing Cash Flow$ 97.39M$ 131.09M$ 53.01M$ 46.41M$ 1.28M
Currency in USD

Stoke Therapeutics Earnings and Revenue History

Income Statement >

Stoke Therapeutics Debt to Assets

Balance Sheet >

Stoke Therapeutics Cash Flow

Cash Flow >

Stoke Therapeutics Forecast EPS vs Actual EPS

Earnings >